TransDigm price target raised to $1,400 from $1,300 at RBC Capital

RBC Capital raised the firm’s price target on TransDigm to $1,400 from $1,300 and keeps an Outperform rating on the shares. The company reported strong Q2 results, with organic revenue growth of 16% and adjusted EBITDA margins of 53.2%, the analyst tells investors in a research note. Defense sales were strong in the quarter, but total commercial aftermarket growth was just 8%, which was a focus for investors, RBC added.